N'-(propan-2-yl)pyridine-4-carbohydrazide
| Title | Journal |
|---|---|
| Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals. | Chemical research in toxicology 20170515 |
| A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans. | Toxicological sciences : an official journal of the Society of Toxicology 20140101 |
| Hydroxycoumarins as selective MAO-B inhibitors. | Bioorganic & medicinal chemistry letters 20120101 |
| 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins. | European journal of medicinal chemistry 20111201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors. | Journal of medicinal chemistry 20111027 |
| Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives. | European journal of medicinal chemistry 20111001 |
| Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors. | Journal of medicinal chemistry 20110728 |
| MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins. | Bioorganic & medicinal chemistry letters 20110715 |
| Homoisoflavonoids: natural scaffolds with potent and selective monoamine oxidase-B inhibition properties. | Journal of medicinal chemistry 20110414 |
| Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives. | European journal of medicinal chemistry 20110401 |
| Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors. | Bioorganic & medicinal chemistry letters 20110115 |
| A predictive ligand-based Bayesian model for human drug-induced liver injury. | Drug metabolism and disposition: the biological fate of chemicals 20101201 |
| Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors. | Bioorganic & medicinal chemistry letters 20101115 |
| Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase. | European journal of medicinal chemistry 20101001 |
| Serendipity and psychopharmacology. | Journal of psychosocial nursing and mental health services 20101001 |
| Synthesis, stereochemical separation, and biological evaluation of selective inhibitors of human MAO-B: 1-(4-arylthiazol-2-yl)-2-(3-methylcyclohexylidene)hydrazines. | Journal of medicinal chemistry 20100909 |
| New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors. | Bioorganic & medicinal chemistry letters 20100901 |
| Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors. | Bioorganic & medicinal chemistry 20100801 |
| Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors. | Bioorganic & medicinal chemistry 20100715 |
| Inhibition of monoamine oxidase activity by cannabinoids. | Naunyn-Schmiedeberg's archives of pharmacology 20100601 |
| Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B. | Bioorganic & medicinal chemistry letters 20100501 |
| Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors. | Bioorganic & medicinal chemistry 20100215 |
| A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors. | Bioorganic & medicinal chemistry 20100201 |
| Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers. | Neuro endocrinology letters 20100101 |
| Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors. | Bioorganic & medicinal chemistry letters 20090901 |
| A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors. | Bioorganic & medicinal chemistry letters 20090615 |
| Chalcones: a valid scaffold for monoamine oxidases inhibitors. | Journal of medicinal chemistry 20090514 |
| Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins. | Journal of medicinal chemistry 20090409 |
| Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. | Journal of medicinal chemistry 20081113 |
| Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones. | Journal of medicinal chemistry 20080828 |
| Metabolism of dopamine by the nasal mucosa. | Journal of pharmaceutical sciences 20061101 |
| (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity. | European journal of pharmacology 20060807 |
| Hydrazide derivatives produce active oxygen species as hydrazine. | Bioorganic chemistry 20051201 |
| Fast-flow EPR spectroscopic observation of the isoniazid, iproniazid, and phenylhydrazine hydrazyl radicals. | Chemical research in toxicology 20040201 |
| Open space swimming test to index antidepressant activity. | Journal of neuroscience methods 20030615 |
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. | The Journal of biological chemistry 20020419 |
| Inhibition of type A monoamine oxidase by coptisine in mouse brain. | Life sciences 20011228 |
| A possible indirect sympathomimetic action of metformin in the arterial vessel wall of spontanously hypertensive rats. | Life sciences 20010720 |
| [Depression in the elderly. Medical treatment]. | Presse medicale (Paris, France : 1983) 20010224 |
| Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. | Hepatology (Baltimore, Md.) 19850101 |
| Epilepsy as an adverse reaction to combined therapy of MAOIs and tricyclics. | Journal of the Royal Society of Medicine 19840401 |
| Iproclozide fulminant hepatitis. Possible role of enzyme induction. | Gastroenterology 19780901 |
| Procaine HCl (Gerovital H3): a weak, reversible, fully competitive inhibitor of monoamine oxidase. | Federation proceedings 19750101 |
| [Brain amines and apomorphine-induced intraspecific aggressive behavior in the rat (author's transl)]. | Psychopharmacologia 19740111 |
| Effects of a hydrazine monoamine oxidase inhibitor (phenelzine) on isoproterenol-induced myocardiopathies in the rat. | The Journal of pharmacology and experimental therapeutics 19670901 |
| Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats. | Proceedings of the Western Pharmacology Society 19660101 |
| The chemical approach to the control of tuberculosis. | Science (New York, N.Y.) 19520808 |